Milojkovic D - Search Results

1

Acquired factor V inhibitor after haematopoietic stem cell transplantation.

Milojkovic D, Patel R, Ford E, Arya R, Mufti G. Milojkovic D, et al. Thromb Haemost. 2007 Sep;98(3):685-7. Thromb Haemost. 2007. PMID: 17849062 No abstract available.

2

Extending the role of allogeneic stem-cell transplantation.

Milojkovic D, Mufti GJ. Milojkovic D, et al. Lancet. 2001 Mar 3;357(9257):652-4. doi: 10.1016/s0140-6736(00)04150-7. Lancet. 2001. PMID: 11247545 No abstract available.

3

Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival.

Lim ZY, Ingram W, Brand R, Akthari M, Milojkovic D, Ho AY, Devereux S, Pagliuca A, Duarte RF, Mufti GJ. Lim ZY, et al. Among authors: milojkovic d. Bone Marrow Transplant. 2007 Oct;40(8):747-52. doi: 10.1038/sj.bmt.1705805. Epub 2007 Aug 20. Bone Marrow Transplant. 2007. PMID: 17704796

4

Prevalence of the activating JAK2 tyrosine kinase mutation V617F in the Budd-Chiari syndrome.

Patel RK, Lea NC, Heneghan MA, Westwood NB, Milojkovic D, Thanigaikumar M, Yallop D, Arya R, Pagliuca A, Gäken J, Wendon J, Heaton ND, Mufti GJ. Patel RK, et al. Among authors: milojkovic d. Gastroenterology. 2006 Jun;130(7):2031-8. doi: 10.1053/j.gastro.2006.04.008. Gastroenterology. 2006. PMID: 16762626

5

Rituximab salvage following relapse after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.

Milojkovic D, Mijovic A, Taylor CG, Mufti GJ, Pagliuca A. Milojkovic D, et al. Br J Haematol. 2000 Sep;110(4):1013-4. doi: 10.1046/j.1365-2141.2000.02270-1.x. Br J Haematol. 2000. PMID: 11054097 Free article. No abstract available.

6

Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently.

Milojkovic D, Buggins AG, Devereux S, Thomas NS, Mufti GJ. Milojkovic D, et al. Leukemia. 2005 Sep;19(9):1699-702. doi: 10.1038/sj.leu.2403864. Leukemia. 2005. PMID: 16015390 No abstract available.

7

Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.

Milojković D, Aldouri M, Pagliuca A, Mufti GJ, Devereux S. Milojković D, et al. Bone Marrow Transplant. 2006 Sep;38(6):461-2. doi: 10.1038/sj.bmt.1705469. Bone Marrow Transplant. 2006. PMID: 16951694 No abstract available.

8

Antiapoptotic microenvironment of acute myeloid leukemia.

Milojkovic D, Devereux S, Westwood NB, Mufti GJ, Thomas NS, Buggins AG. Milojkovic D, et al. J Immunol. 2004 Dec 1;173(11):6745-52. doi: 10.4049/jimmunol.173.11.6745. J Immunol. 2004. PMID: 15557167

9

Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways.

Buggins AG, Milojkovic D, Arno MJ, Lea NC, Mufti GJ, Thomas NS, Hirst WJ. Buggins AG, et al. Among authors: milojkovic d. J Immunol. 2001 Nov 15;167(10):6021-30. doi: 10.4049/jimmunol.167.10.6021. J Immunol. 2001. PMID: 11698483

10

Dose-limiting dermatological toxicity secondary to imatinib mesylate (STI571) in chronic myeloid leukaemia.

Milojkovic D, Short K, Salisbury JR, Creamer D, du Vivier AW, Mufti GJ. Milojkovic D, et al. Leukemia. 2003 Jul;17(7):1414-6. doi: 10.1038/sj.leu.2402991. Leukemia. 2003. PMID: 12835733 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters